Lexaria Bioscience (LEXX) Debt Ratio (2011 - 2022)

Lexaria Bioscience has disclosed Debt Ratio across 12 years of filings, most recently posting 0.0 for Q2 2022.

• Debt Ratio for Q2 2022 came in at 0.0, up 589.24% year-over-year; the trailing twelve-month figure through May 2022 was 0.0 (up 589.24% YoY), and the FY2021 annual result was 0.0, down 94.49% from the prior year.
• Debt Ratio came in at 0.0 for Q2 2022 at Lexaria Bioscience, up from 0.0 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 1.51 in Q1 2021 to a low of 0.0 in Q2 2021.
• The 5-year median for Debt Ratio is 0.0 (2018), against an average of 0.1.
• Across the five-year window, Debt Ratio sank 99.39% in 2018 and surged 186907.15% in 2021, its largest moves.
• Lexaria Bioscience's Debt Ratio stood at 0.01 in 2018, then surged by 121.72% to 0.01 in 2019, then soared by 300.74% to 0.05 in 2020, then plunged by 98.77% to 0.0 in 2021, then surged by 30.0% to 0.0 in 2022.
• The last three Debt Ratio figures came in at 0.0 (Q2 2022), 0.0 (Q4 2021), and 0.0 (Q3 2021), per Business Quant data.